Stout Jay S (CIK 1702969) reported 17 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-26). Recent activity: Sell IMVT (33,277 shares), Sell IMVT (6,723 shares), Sell IMVT (2,754 shares), Sell IMVT (8,614 shares), Sell IMVT (1,518 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-26 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Sell | 33,277 | $1.3M |
| 2026-06-26 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Sell | 6,723 | $261,794 |
| 2026-04-24 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Sell | 2,754 | $81,573 |
| 2026-04-10 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Sell | 8,614 | $213,886 |
| 2026-04-10 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Sell | 1,518 | $37,692 |
| 2026-04-09 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Buy | 66,937 | $0 |
| 2026-01-23 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Sell | 1,977 | $51,461 |
| 2026-01-09 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Sell | 1,148 | $30,433 |
| 2026-01-09 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Sell | 55 | $1,481 |
| 2025-10-24 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Sell | 2,520 | $47,956 |
| 2025-10-10 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Sell | 1,585 | $25,836 |
| 2025-07-25 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Sell | 2,805 | $50,911 |
| 2025-07-11 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Sell | 1,519 | $26,188 |
| 2025-04-25 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Sell | 1,925 | $28,471 |
| 2025-04-11 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Sell | 5,004 | $65,002 |
| 2025-04-03 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Buy | 76,181 | $0 |
| 2025-01-24 | Immunovant, Inc. (IMVT) | Chief Technology Officer | Sell | 2,195 | $51,780 |
Source: SEC Form 4 filings · as of 2026-06-26